Genral neurophysiology (biochemical aspects).
D000367:Age Factors; D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy; D001812:Blood-Brain Barrier; D001921:Brain / Q000196:embryology / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism / Q000503:physiopathology*; D001927:Brain Diseases / Q000503:physiopathology; D002560:Cerebrovascular Circulation; D002561:Cerebrovascular Disorders / Q000503:physiopathology; D000242:Cyclic AMP / Q000378:metabolism; D003677:Deficiency Diseases / Q000150:complications / Q000196:embryology / Q000503:physiopathology; D004032:Diet / Q000009:adverse effects; D004285:Dogs; D005260:Female; D006801:Humans; D006892:Hydroxydopamines / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D066298:In Vitro Techniques; D007223:Infant; D007228:Infant Nutrition Disorders / Q000503:physiopathology; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000209:etiology; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D011247:Pregnancy; D011833:Radiation Injuries, Experimental / Q000196:embryology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013045:Species Specificity; D013312:Stress, Physiological / Q000378:metabolism
D006892:Hydroxydopamines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008094:Lithium; D000242:Cyclic AMP